<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03712657</url>
  </required_header>
  <id_info>
    <org_study_id>TJH</org_study_id>
    <nct_id>NCT03712657</nct_id>
  </id_info>
  <brief_title>ERAS for Pediatric Acute Appendicitis</brief_title>
  <acronym>EPAA</acronym>
  <official_title>Multi-center Research Manual for the Perioperative Application of Enhanced Recovery After Surgery in Pediatric Acute Appendicitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicenter, prospective randomized controlled study is designed to applicate&#xD;
      perioperative Enhanced recovery after surgery (ERAS) management for children with acute&#xD;
      appendicitis, the aim is to promote postoperative recovery, shorten the hospital length of&#xD;
      stay, and reduce the incidence of postoperative complications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is through multi-center prospective RCT research, to discuss the&#xD;
      application of ERAS in children with acute appendicitis, including its preoperative&#xD;
      rehydration, postoperative analgesia, preoperative and postoperative antibiotics application,&#xD;
      as well as the discharge standards and so on. The major outcome is whether it can reduce the&#xD;
      length of stay in hospital (LOS), secondary outcomes are included the incidence of&#xD;
      postoperative complications and postoperative readmission rate, etc.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>length of stay</measure>
    <time_frame>through study completion, an average of 7 days</time_frame>
    <description>less hospital length of stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>first time for postoperative feeding</measure>
    <time_frame>up to 72 hours</time_frame>
    <description>earlier postoperative feeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>first time for postoperative exercising</measure>
    <time_frame>1-2 days</time_frame>
    <description>earlier postoperative exercising</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of postoperative complication</measure>
    <time_frame>1 months</time_frame>
    <description>less postoperative complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of re-operation</measure>
    <time_frame>1 months</time_frame>
    <description>less rate of re-operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of re-admission</measure>
    <time_frame>1 months</time_frame>
    <description>less rate of re-admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Pediatric Disorder</condition>
  <condition>Appendicitis</condition>
  <arm_group>
    <arm_group_label>ERAS group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>interventions: 1.preoperative pain control; 2.avoiding application of ureter; 3.avoiding application of gastric tube; 4.avoiding application of irrigation; 5.avoiding application of drainage; 6.early exercising postoperatively; 7.early oral feeding postoperatively; 8.early discharging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conservative group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>normal treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>ERAS</intervention_name>
    <description>preoperative pain control;&#xD;
avoiding application of ureter;&#xD;
avoiding application of gastric tube;&#xD;
avoiding application of irrigation;&#xD;
avoiding application of drainage;&#xD;
early exercising postoperatively;&#xD;
early oral feeding postoperatively;&#xD;
early discharging.</description>
    <arm_group_label>ERAS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ages&lt;14; no gender limitation;&#xD;
&#xD;
          -  Alvarado scores â‰¥7;&#xD;
&#xD;
          -  preoperative radiography examination indicated appendicitis;&#xD;
&#xD;
          -  Patients or their legal representatives have signed &quot;informed consent&quot;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  complicated life-threatening disease;&#xD;
&#xD;
          -  perioperative exploration not appendicitis;&#xD;
&#xD;
          -  Recently participated in other clinical trials within 3 months;&#xD;
&#xD;
          -  Researchers found not fit to participate in this trial for any condition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiexiong Feng, MD</last_name>
    <phone>0028-13986086129</phone>
    <email>fengjiexiong@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tianqi Zhu, MD</last_name>
    <phone>0028-13986295423</phone>
    <email>zhutianqi84@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tianqi Zhu, MD PhD</last_name>
      <phone>13986295423</phone>
      <email>zhutianqi84@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 7, 2018</study_first_submitted>
  <study_first_submitted_qc>October 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Feng Jiexiong</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>ERAS</keyword>
  <keyword>Pediatric surgery</keyword>
  <keyword>Emergency</keyword>
  <keyword>Both of systolic and diastolic will be measured</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified individual participant data for all primary and secondary outcome measures will be made available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>data will be available within 6 months of study completion.</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by an external independent review panel. requestors will be required to sign a data access agreement.</ipd_access_criteria>
    <ipd_url>http://bethesda.org</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

